Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 20 of 50:
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
Gene Compound Assay Inh Ic50 Ki View
adrenergic receptor, alpha 1b LYSERGOL Adrenergic alpha1B 71% 4.726uM 2.616uM View
sodium channel, nonvoltage-gated 1, delta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, nonvoltage-gated 1 alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type X, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type IX, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage gated, type VIII, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type VII, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type IV, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type IV, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type III, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type II, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type II, alpha 2 PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type I, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type I, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
A3 adenosine receptor NELFINAVIR Adenosine A3 71% 14.796uM 8.363uM View
adrenergic receptor, alpha 1a TACRINE Adrenergic alpha1A 71% 2.749uM 1.113uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PROCHLORPERAZINE Dopamine Transporter 71% 1.735uM 1.379uM View
monoamine oxidase A PIOGLITAZONE Monoamine Oxidase MAOA 71% 35.069uM NoneNone View
monoamine oxidase A PIOGLITAZONE Monoamine Oxidase MAOA 71% 35.069uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A PIPAMAZINE Serotonin 5-HT1A 71% 1.782uM 1.018uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) GW-1929 CYP450-2C9 Inhibition 71% 4uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 GW-1929 CYP450-2C9 Inhibition 71% 4uM NoneNone View
epidermal growth factor receptor GW-1929 Protein Tyrosine Kinase, EGF Receptor 71% 10.896uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 7 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 6 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 5 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 4 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 3 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 2 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 1 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, beta 4 subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, beta 3 subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, beta 2 subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, alpha 1F subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, beta 1 subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
sodium channel, nonvoltage-gated 1 alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel associated protein 1 AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C CHLOROXYLENOL Serotonin 5-HT2C 69% NoneNone NoneNone View
nuclear receptor subfamily 3, group C, member 1 PREGNENOLONE-16ALPHA-CARBONITRILE Glucocorticoid 69% 13.957uM 6.344uM View
adrenergic receptor, alpha 1b ERGONOVINE Adrenergic alpha1B 69% NoneNone NoneNone View
androgen receptor FLUOCINONIDE Testosterone 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
epidermal growth factor receptor FLUPHENAZINE Protein Tyrosine Kinase, EGF Receptor 69% 40.107uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 LABETALOL Serotonin Transporter 66% NoneNone NoneNone View
adrenergic receptor, beta 2 BROMOCRIPTINE Adrenergic beta2 66% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 ISOEUGENOL Cyclooxygenase COX-1 66% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) ISOEUGENOL Cyclooxygenase COX-1 66% NoneNone NoneNone View
chemokine (C-C motif) receptor 2 CISPLATIN Chemokine CCR2B 66% 18.142uM 7.012uM View
5-hydroxytryptamine (serotonin) receptor 2A LOPERAMIDE Serotonin 5-HT2A 66% NoneNone NoneNone View
A3 adenosine receptor N,N'-DIPHENYL-P-PHENYLENEDIAMINE Adenosine A3 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
Sigma-2 Receptor IRINOTECAN Sigma2 66% NoneNone NoneNone View
adrenergic receptor, alpha 2a IMIQUIMOD Adrenergic alpha2A 66% NoneNone NoneNone View
opioid receptor, kappa 1 RITONAVIR Opiate kappa 66% 13.655uM 5.462uM View
Sigma-2 Receptor NORETHINDRONE ACETATE Sigma2 66% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) OXICONAZOLE Protein Tyrosine Kinase, HER2 Receptor 66% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) OXICONAZOLE Protein Tyrosine Kinase, HER2 Receptor 66% NoneNone NoneNone View
mitogen activated protein kinase 14 EPALRESTAT Protein Serine/Threonine Kinase, p38alpha 66% NoneNone NoneNone View
mitogen-activated protein kinase 14 EPALRESTAT Protein Serine/Threonine Kinase, p38alpha 66% NoneNone NoneNone View
opioid receptor, sigma 1 ORPHENADRINE Sigma1 66% NoneNone NoneNone View
arachidonate 15-lipoxygenase, second type RESVERATROL Lipoxygenase 15-LO 66% NoneNone NoneNone View
arachidonate 15-lipoxygenase RESVERATROL Lipoxygenase 15-LO 66% NoneNone NoneNone View
arachidonate 15-lipoxygenase RESVERATROL Lipoxygenase 15-LO 66% NoneNone NoneNone View
Sigma-2 Receptor CETYLPYRIDINIUM BROMIDE Sigma2 66% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 RALOXIFENE Muscarinic M5 66% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 DIPHENHYDRAMINE Dopamine Transporter 66% NoneNone NoneNone View
mu-opioid receptor MOR HALOPROGIN Opiate mu 66% NoneNone NoneNone View
chemokine (C-C motif) receptor 5 DISULFIRAM Chemokine CCR5 66% 23.661uM 18.284uM View
ATPase, Na+/K+ transporting, beta 1 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
histamine receptor H 2 DEXCHLORPHENIRAMINE Histamine H2 71% 8.368uM 8.228uM View
thromboxane A synthase 1 ERGOCORNINE Thromboxane Synthetase 71% 1.993uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) ERGOCORNINE Thromboxane Synthetase 71% 1.993uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A SULCONAZOLE Serotonin 5-HT2A 71% 3.929uM 1.122uM View
5-hydroxytryptamine (serotonin) receptor 2C SULCONAZOLE Serotonin 5-HT2C 71% 2.785uM 1.459uM View
Cytochrom P450-2C19 monooxygenase MC 258714 CYP450-2C19 Inhibition 71% 3uM NoneNone View
Cytochrom P450-2D6 monooxygenase CELECOXIB CYP450-2D6 Inhibition 71% 1uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C U-78517F Serotonin 5-HT2C 71% 7.563uM 3.962uM View
cholinergic receptor, muscarinic 2 AMOXAPINE Muscarinic M2 71% 2.623uM .933uM View
endothelin receptor type A AMIODARONE Endothelin ETA 71% 26.288uM 16.177uM View
phosphodiesterase 4A, cAMP specific RO 20-1724 Phosphodiesterase PDE4 71% 11.316uM NoneNone View
phosphodiesterase 4C, cAMP-specific RO 20-1724 Phosphodiesterase PDE4 71% 11.316uM NoneNone View
phosphodiesterase 4D RO 20-1724 Phosphodiesterase PDE4 71% 11.316uM NoneNone View
phosphodiesterase 4B, cAMP specific RO 20-1724 Phosphodiesterase PDE4 71% 11.316uM NoneNone View
5-hydroxytryptamine receptor 6 DICYCLOMINE Serotonin 5-HT6 71% 3.065uM 1.423uM View
5-hydroxytryptamine (serotonin) receptor 1B CLOZAPINE Serotonin 5-HT1B 71% 2.109uM .959uM View
ATPase, Na+/K+ transporting, alpha 4 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
opioid receptor, sigma 1 PERHEXILINE Sigma1 71% 2.5992uM 1.0924uM View
cholinergic receptor, muscarinic 4 SULOCTIDIL Muscarinic M4 71% 4.561uM .6361uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ZINC CHLORIDE Adrenergic, Norepinephrine Transporter 71% 7.0083uM 6.9504uM View
opioid receptor, sigma 1 PROPAFENONE Sigma1 71% 2.61uM 1.097uM View
Sigma-2 Receptor 1,3-DIPHENYLGUANIDINE Sigma2 71% 2.641uM 1.625uM View
5-hydroxytryptamine (serotonin) receptor 2C 4-NONYLPHENOL Serotonin 5-HT2C 71% 2.571uM 1.347uM View
adrenergic receptor, alpha 2a THIORIDAZINE Imidazoline I2, Central 71% 3.663uM 2.442uM View
adrenergic receptor, alpha 2c (Non-specific probe) THIORIDAZINE Imidazoline I2, Central 71% 3.663uM 2.442uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 HYDROXYPROGESTERONE Dopamine Transporter 71% 6.905uM 5.486uM View
Cytochrom P450-2D6 monooxygenase LEVOBUPIVACAINE CYP450-2D6 Inhibition 71% .1964uM NoneNone View
Cytochrom P450-2D6 monooxygenase PIPERILATE ETHOBROMIDE CYP450-2D6 Inhibition 71% .521uM NoneNone View
Cytochrom P450-2D6 monooxygenase THIMEROSAL CYP450-2D6 Inhibition 71% 3uM NoneNone View
Cytochrom P450-2D6 monooxygenase AMOXAPINE CYP450-2D6 Inhibition 71% 10uM NoneNone View
Cytochrom P450-2D6 monooxygenase CLOMIPRAMINE CYP450-2D6 Inhibition 71% 3.9465uM NoneNone View
Cytochrom P450-2C19 monooxygenase TIBOLONE CYP450-2C19 Inhibition 71% 3uM NoneNone View
Cytochrom P450-2C19 monooxygenase PAPAVERINE CYP450-2C19 Inhibition 71% .762uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B BERBERINE CHLORIDE Serotonin 5-HT2B 71% 3.437uM 2.187uM View
adrenergic receptor, alpha 2a METHYLERGONOVINE Imidazoline I2, Central 71% 2.934uM 1.956uM View
adrenergic receptor, alpha 2c (Non-specific probe) METHYLERGONOVINE Imidazoline I2, Central 71% 2.934uM 1.956uM View
dopamine receptor 2 MAPROTILINE Dopamine D2L 71% 3.463uM 1.154uM View
calcium channel, voltage-dependent, gamma subunit 8 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 7 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 6 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 5 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 4 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 3 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 2 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 1 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, beta 4 subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, beta 3 subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View